TIMELINE: The Evolution of Telehealth in Prescribing of Controlled Substances
As the DEA prepares to unveil new regulations for the telemedicine prescribing of controlled substances, many are eager to see how these changes may reshape the policy landscape for telemedicine delivery of care. With this in mind, the following provides a timeline of how we arrived at this juncture and what may lie ahead on the policy horizon.